5 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Micropharma Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile Delayed release capsule, L. reuteri NCIMB 30242, escalated dose, Standard vegetarian capsule, L. reuteri NCIMB 30242, escalated dose - Hypercholesterolemia | Phase 2 | Completed | Micropharma Limited | 10 | 2013-11-01 | 2014-08-15 |
| Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule One-a-Day L. reuteri NCIMB 30242 supplement capsule, One-a-Day placebo capsule - Hypercholesterolemia | Phase 2 | Completed | Micropharma Limited | 150 | 2012-08-01 | 2014-06-26 |
| Efficacy of Cardioviva™ Probiotic Supplement Capsule Formulation Cardioviva™ supplement capsule, Placebo capsule - Hypercholesterolemia | Phase 2 | Completed | Micropharma Limited | 131 | 2011-05-01 | 2011-11-02 |
| Efficacy of Cardioviva™ Probiotic Yogurt Formulation Cardioviva™ yogurt, Placebo yogurt - Hypercholesterolemia | Phase 2 | Completed | Micropharma Limited | 150 | 2008-09-01 | 2012-07-02 |
| Efficacy of Two Yogurt Formulations in Healthy Humans L. Amylovorus, L. Fermentum - Healthy | Phase 1 | Completed | University of Manitoba | 30 | 2007-09-01 | 2011-08-04 |
Canada (1) · Czechia (1)
Mitchell L Jones, MD, MEng (1)